BUZZ-Edwards Lifesciences gains on upbeat 2026 profit outlook
Reuters
Feb 11
BUZZ-Edwards Lifesciences gains on upbeat 2026 profit outlook
** Shares of medical device maker Edwards Lifesciences EW.N up 3.3% at $79.60 after the bell
** EW forecasts 2026 profit above estimates, betting on robust demand for its artificial heart valves and other medical devices
** Expects 2026 adjusted profit to be in the range of $2.90 to $3.05 per share vs estimate of $2.89 per share — data compiled by LSEG
** Posts Q4 net sales of $1.57 billion vs estimates of $1.55 billion
** In 2025, EW shares rose 15.2%
(Reporting by Sumit Saha in Bengaluru)
((Sumit.Saha@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.